TrialNature medicine2021

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.

Patrick M Forde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.